NewGLab Pharma Co Ltd
KOSDAQ:214870
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
W
|
Wai Kee Holdings Ltd
HKEX:610
|
HK |
|
E
|
EM-Tech Co Ltd
KOSDAQ:091120
|
KR |
|
Y
|
Yau Lee Holdings Ltd
HKEX:406
|
HK |
|
ABC-Mart Inc
TSE:2670
|
JP |
|
Imax Corp
NYSE:IMAX
|
CA |
|
Parkit Enterprise Inc
XTSX:PKT
|
CA |
|
Beijing Jiaoda Singal Technology Co Ltd
SZSE:300851
|
CN |
|
L
|
Lendingtree Inc
LSE:0JTZ
|
US |
|
Z
|
Zhejiang Xinzhonggang Thermal Power Co Ltd
SSE:605162
|
CN |
|
Enprise Group Ltd
NZX:ENS
|
NZ |
|
A
|
Aktia Bank Abp
OMXH:AKTIA
|
FI |
NewGLab Pharma Co Ltd
Total Current Liabilities
NewGLab Pharma Co Ltd
Total Current Liabilities Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Total Current Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
N
|
NewGLab Pharma Co Ltd
KOSDAQ:214870
|
Total Current Liabilities
₩38.1B
|
CAGR 3-Years
-21%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
N/A
|
|
|
Woojin Inc
KRX:105840
|
Total Current Liabilities
₩28B
|
CAGR 3-Years
-7%
|
CAGR 5-Years
-12%
|
CAGR 10-Years
-5%
|
|
|
F
|
FiberPro Inc
KOSDAQ:368770
|
Total Current Liabilities
₩7.6B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
R
|
Robostar Co Ltd
KOSDAQ:090360
|
Total Current Liabilities
₩22B
|
CAGR 3-Years
-22%
|
CAGR 5-Years
-17%
|
CAGR 10-Years
-8%
|
|
|
P
|
Park Systems Corp
KOSDAQ:140860
|
Total Current Liabilities
₩73.4B
|
CAGR 3-Years
23%
|
CAGR 5-Years
22%
|
CAGR 10-Years
38%
|
|
|
W
|
Woori Technology Inc
KOSDAQ:032820
|
Total Current Liabilities
₩116.1B
|
CAGR 3-Years
28%
|
CAGR 5-Years
21%
|
CAGR 10-Years
12%
|
|
NewGLab Pharma Co Ltd
Glance View
NewGLAB Pharma Co., Ltd. engages in the manufacture of closed-circuit television camera and equipment. The company is headquartered in Bucheon, Gyeonggi-Do. The company went IPO on 2015-10-13. The firm's product portfolio consists of general analog cameras that used for CCTVs, high definition (HD) analog cameras, HD-serial digital interface (SDI) cameras, extend (EX)-SDI cameras, internet protocol (IP) cameras that used for network CCTVs, digital video recorders (DVRs) that used for image storage devices, network video recorders (NVRs) and others. In addition, the Company is involved in the business of 5G smartphone distribution. The firm distributes its products within domestic market and to overseas markets.
See Also
What is NewGLab Pharma Co Ltd's Total Current Liabilities?
Total Current Liabilities
38.1B
KRW
Based on the financial report for Dec 31, 2024, NewGLab Pharma Co Ltd's Total Current Liabilities amounts to 38.1B KRW.
What is NewGLab Pharma Co Ltd's Total Current Liabilities growth rate?
Total Current Liabilities CAGR 5Y
-4%
Over the last year, the Total Current Liabilities growth was -24%. The average annual Total Current Liabilities growth rates for NewGLab Pharma Co Ltd have been -21% over the past three years , -4% over the past five years .
